Monday, April 1, 2013

What are Directors Worth, and What do They Owe?

All weekend, I've been thinking about James B. Stewart's excellent column in Friday's New York Times about "bad directors and why they aren't thrown out." (Full column, here)

His "shining" example of a disastrously bad board is Hewlett-Packard. Item by item, Stewart follows the board's non-actions through the Mark Hurd sexual harassment disaster, through the hiring of fired SAP chief Leo Apotheker, the "wildly overpriced" acquisition of Autonomy, a UK software maker, and eventually the firing of Apotheker (with $13 million in "termination benefits") -- during all of which the company's stock slid by more than half.

To add insult to Hewlett-Packard shareholder's injuries: "all 11 HP directors were re-elected on March 20."

In its proxy materials, HP recommended that the entire slate of directors be re-elected, "citing the risk of 'destabilizing' the company by changing directors in an 'abrupt and disorderly manner.'"

It's hard to see how the company could be more destabilized by a bunch of newcomers than it already has been by a bunch of rubber-stamps.

What do directors owe the companies on whose boards they serve? For their generous salaries for part-time work (per Stewart's article, HP directors "received a mix of cash and stock payments ranging from $292,000 to $380,000 in 2012."), I think that the least they owe the company is a measure of integrity.

Did no one on the board question the hiring of Apotheker? Did no one question the price paid for Autonomy? Did no one question.... Oh you get the point.

I know the power of group-think, that impulse to go along with what everybody seems to think is right.

Was that the problem? Or, in this case, was it the power of that hefty cash-and-stock incentive? Rock the boat too much, and you might find yourself out of favor, and out of a cushy little piece of cash.

Compensation experts are always saying that top-dollar needs to be paid to entice the most talented executives and board members. But maybe top-dollar is just a little too much.

Today's Times carries a DealBook column by Susanne Craig (here) on the soaring pay for bank boards. You thought HP directors did well? According to Craig, at Goldman Sachs, "the average annual compensation for a director ...was $488,709 in 2011, the last year for which data is available, up more than 50 percent from 2008", and some directors earned over $500,000.

You know, I have a bunch of household renovation projects I'd like to take up, so I could use a little extra cash. I'd be happy to serve on the HP board.

I don't see how I could do worse than the current crop.

Wednesday, March 20, 2013

Loan Sharks Still Swimming Offshore

Payday lenders are among the scummiest people on the planet, I say without fear of argument, preying on the most financially vulnerable among us.

Unlike the loan sharks of yore, they no longer threaten to break your kneecaps, but short of that -- pretty much anything goes.

But when you're living teeny-paycheck-to-teeny-paycheck, a sudden emergency can leave you with nowhere else to turn. All of a sudden, an interest rate in excess of 500 percent can seem, if not reasonable, at least an option (especially because the rate is not usually presented in APR terms, but as "I can give you $100 now, and you'll pay me back, plus $20, in two weeks," which sounds almost reasonable.).

If you can't pay the full $120 two weeks from now, your lender will "kindly" accept partial payment and roll over the loan... You can see how quickly someone can get lost in debt.

Because  payday lenders rely on those whose financial options are few, and whose financial acumen is often also low, some states (15 to date) ban such loans. The lenders' solution? Move online.

New York Times journalist Jessica Silver-Greenberg reported late last month that these lenders have found willing co-conspirators in the major banks (full article, here). The banks themselves don't dirty their hands with such loans directly, but they're enablers, permitting "the lenders to withdraw payments automatically from borrowers’ bank accounts, even in states where the loans are banned entirely. In some cases, the banks allow lenders to tap checking accounts even after the customers have begged them to stop the withdrawals." (emphasis added)

The bankers' explanation? They are "simply serving customers who have authorized the lenders to withdraw money from their accounts."

This is ingenuous, at best.

Especially since the withdrawals often "set off a cascade of [highly profitable] fees from problems like overdrafts."

I doubt that there are any truly ethically-minded payday lenders, but moving online has made it even easier for the true scam artists to operate.
While the loans are simple to obtain — some online lenders promise approval in minutes with no credit check — they are tough to get rid of. Customers who want to repay their loan in full typically must contact the online lender at least three days before the next withdrawal. Otherwise, the lender automatically renews the loans at least monthly and withdraws only the interest owed. 

Customers have the legal right, under federal law, to stop such automatic withdrawals. But many have complained that their banks have ignored their requests to do so.

But there's a glimmer of good news.

In today's Times, Silver-Greenberg reports that JP Morgan Chase is changing its policy to give its customers greater control to halt the automatic withdrawals and close their accounts (full story, here). Unfortunately, both Bank of America and Wells Fargo said that their policies regarding payday loans would be unchanged.

It's also only a glimmer of good news because JP Morgan Chase said that part of the policy change would include "training to their employees so that stop-payment requests are honored."

Wouldn't you expect your bank to honor your request to stop payment from your account anyway?!?


Monday, March 11, 2013

$8.3 Million. And Counting.

How much is a bad business decision going to cost you? It depends, of course.

Johnson & Johnson got one answer last week: $8.3 million and counting.

That was the jury award ($338,000 for medical expenses, and $8 million for pain and suffering) from the first of many cases against Johnson & Johnson's DePuy Orthopedics unit for its now-recalled metal-on-metal artificial hip.

The 12-member jury, however, did not award punitive damages, accepting that the company did not act "with fraud or malice". (A complete news article on the decision, by Barry Meier in Friday's New York Times, can be found here.) Meier wrote that

Internal Johnson & Johnson documents that became public during the trial indicated that the company executives were told by surgeons, who were also paid consultants to the design maker, that the design of the A.S.R. [Articular Surface Replacement, the full name of the metal-on-metal hip replacement] was flawed. In addition, some surgeons also urged the device maker to slow sales of the implant or stop them completely....

In the case, evidence was also presented that showed Johnson & Johnson considered redesigning the A.S.R. to reduce its problems, but then abandoned the project because the implant's sales did not justify the costs of the redesign.

Johnson & Johnson did move to recall the device, introduced first in 2003, in 2010 "when data from an orthopedic registry in Britain showed that its failure rate was higher than normal."

In fact, about four in ten patients with an A.S.R. would need a second operation within five years to have the implant replaced. In comparison, traditional artificial hips, made of a combination of metal and plastic, generally have a failure rate of less than 5%.

DePuy has said that it will appeal the damage award.

The second of more than 10,000 cases goes to trial today in Chicago.

Thursday, February 28, 2013

Thinking About Chocolate Rather Than Eating It


As a Swiss citizen, eating chocolate is my favorite way of supporting the national economy. Alas, this Lenten season, I can only think about it, rather than indulging in it.

And thinking about chocolate can be dispiriting. The truth is that the fabulous final product often hides an ugly sourcing story. I wrote about this a few months ago (here), when Whole Foods removed Hershey Brand's high-end Scharffen Berger chocolate line from its shelves because of Hershey's " failure to assure that the cocoa is sourced without the use of forced child labor."

Forced child labor in West Africa's huge cocoa market is only one sad story from the chocolate front. Another is the continued exploitation of women workers, who routinely earn less than half of what men are paid, for the same job.

A recent report from Oxfam (here; note: launches as PDF) notes that while global chocolate sales keep rising (breaking $100 billion in 2011), the tight control on the market by its largest players has kept that success from reaching the farmers who produce the base crop. Ninety percent of the world's cocoa is grown by small-scale farmers, and most -- especially in West Africa, from which 70% of cocoa is sourced -- live below the poverty line.

And it is the women who suffer the most.

One example should suffice:
While everyone struggles to survive on the meager income made from cocoa, it is the women laborers who appear to fare the worst. Agnes Gabriel, a 37-year-old migrant worker living in Ayetoro-Ijesa [Nigeria] says that one of the jobs she is hired to do on local cocoa farms is lug water to be mixed with pesticides. Other tasks include removing the beans from their pods during harvest time, carrying them to the site where they will ferment and then helping with the drying process. For her efforts, she earns 500 Naira a day, or just over $3. Farmers say women are paid $2–3 for a typical day’s work, while men earn about $7 per day.

What should the companies be doing? The Oxfam report has three steps it recommends: (1) "know and show" how women are treated in their supply chains; (2) Commit to the adoption of a "plan of action" to increase opportunities for women and address inequalities in women’s pay and working conditions; and (3) influence other powerful and relevant public and private actors to address gender inequality (for example, by signing on to the UN Women's Empowerment Principles, here).

What can any one individual do? Know what you buy.

The Food Empowerment Project has a "Food Is Power" list of chocolate products that appear to be produced from areas where child labor / slavery have been reduced if not eliminated (here), but it does not address the issue of gender discrimination.

Oxfam has a "Behind the Brands" scorecard, not limited to chocolate, where consumers can learn more about the supply-chain ethics behind some of their favorite products. Sadly, one of my favorite non-Lenten indulgences, Toblerone, produced by Mondelez International, does not score well on any of Oxfam's seven vectors (land, women, farmers, workers, climate, transparency, water).

I'll happily pay more for chocolate that I know is ethically sourced. But I won't pay more for chocolate if it just means that the CEO's pay goes from $4.2 million per year to $4.4 million.

Transparency, folks. That's what I'm looking for.


Wednesday, February 20, 2013

A BA in Alphabetizing


Let's say you run an office that generates a lot of paper (side question: What ever happened to the "paperless office"?). Perhaps it's a real estate office. Or a medical office. Or a law firm. Whichever the case, you decide to hire a file clerk to help you manage all that paper.

What's the critical qualification for that job? How about: Knowing one's way around the alphabet.

After that... well, there isn't much, is there?

But increasingly, according to Catherine Rampell's article in today's New York Times, the new minimum requirement is a B.A.

As one example, Rampell writes about a growing law firm in Atlanta which "hires only people with a bachelor's degree, even for jobs that do not require college-level skills."

Why does that bother me? After all, in a terrible job market, why shouldn't an employer hire the highest-quality employee possible?

First of all, there's no guarantee that a college graduate will make a more effective file clerk than a high-school graduate.

Secondly, as Rampell writes,
This up-credentialing is pushing the less educated even further down the food chain, and it helps explain why the unemployment rate for workers with no more than a high school diploma is more than twice that for workers with a bachelor's degree: 8.1 percent versus 3.7 percent.

Me, I would worry that my college-graduate file clerk would take off as soon as something even a little more challenging showed up, leaving me with the cost of finding yet another file clerk.

But that's not the heart of the issue for me. The heart is, in an increasingly unequal society, we keep finding ways to make it harder yet for the poor to break out of the poverty cycle. I've written before about employers who will only consider job applicants who are currently employed, adding insult to injury for the long-term unemployed, and about the friend-of-a-friend hiring practices, that can so easily slide into discrimination against people "not like us".

While many more Americans today earn undergraduate degrees than was the case, say, 50 years ago, the rapid rise in the cost of a higher education has made that rung of the ladder a much harder one for the poor to reach. And now they can't even get hired as a file clerk?

The managing partner of the Atlanta law firm likes his college-graduates requirement, because "a floor of college attainment also creates more office camaraderie..... There is a lot of trash-talking of each other's college football teams, for example."

Rampell quotes him as saying,
You know, if we had someone here with just a  GED or something, I can see how they might feel slighted by the social atmosphere here. There really is something sort of cohesive or binding about the fact that all of us went to college.

What's wrong with that? Just try replacing that final phrase "went to college" with: "are white" or "are Christians" or "belong to the country club". Now how does it sound?

But my "favorite" comment was from an executive recruiter, explaining the BAs-only requirement: "When you get 800 resumes for every job ad, you need to weed them out somehow."

Funny, I thought that was what you hired recruiters for.

Tuesday, February 19, 2013

If the Doctors Don't Speak Out, Who Will?

I hadn't planned to write anything about the first trial -- of what is likely to be several -- of Johnson & Johnson for the failure of the artificial hips manufactured and sold by its DePuy Orthopaedics division.

For one thing, I've written about J&J and DePuy before (e.g., here). For another, it was just too damn depressing.

Two years ago, I wondered whether the DePuy complaints were evidence of systemic problems at J&J. I'm not really wondering any more.

The news from the courtroom has been pretty bad. Late last month, in a New York Times article, reporter Barry Meier wrote that J&J's own internal reviews had "found that the company had not adequately assessed the device’s potential risks before it was used in more than 90,000 patients" (full article, here). More damaging still:
DePuy conducted the post-mortem review of the A.S.R. in November 2010, just three months after it recalled the all-metal implant, but it never released the analysis.
The metal-on-metal "Articular Surface Replacement" (ASR) device failed within five years in about 40% of patients who received it. Among other problems, the metal-on-metal format resulted in the release of minute metal fragments into the patient, causing, in some cases, serious internal damage. Problems with the DePuy device began to surface shortly after its release;
In previously recorded testimony presented in court on Wednesday, DePuy’s president, Andrew Ekdahl, was shown an e-mail in which he was warned about the A.S.R.’s problems nearly three years before it was recalled.

But what really got me thinking was an analysis that Meier wrote in the "Sunday Review" section of the 17 February New York Times, titled "Doctors Who Don't Speak Out." (full article, here).
It might not be surprising to find that executives acted to protect a company's bottom line. Still, the Johnson & Johnson episode is also illuminating a broader medical issue: while experts say that doctors have an ethical obligation to warn their peers about bad drugs or medical devices, they often do not do so.

Meier quotes a Yale School of Medicine professor: "Questioning the status quo in medicine is not easy."

To be fair, questioning the status quo is rarely easy -- whether you're talking about medicine, politics, academia, credit default swaps, or nutritional guidelines.

Meier outlines several reasons why doctors would be reluctant to "warn their peers about bad drugs or medical devices": fear of a lawsuit; belief that a problem is really an anomaly; aversion to reporting; and (I believe most importantly) financial ties to a drug or device manufacturer.

I've written before about the overly-cozy relationship between doctors and drug and device companies, about dental-device manufacturers who underwrite an entire issue of the Journal of the American Dental Association (here), about pharmaceutical companies writing entire textbooks (here), and about plans to require drug companies to disclose payments made to doctors for research, consulting, travel, and entertainment (here).

It's everywhere, and it needs to stop. And doctors need to develop a culture where -- to borrow a phrase from high-quality assembly-line manufacturing -- it's more important to stop the line for a possible problem (that turns out not to be one) than to let a real problem roll by. Because the patients are the ones who are suffering from their doctors' silence.

What ever happened to, "First, do no harm"?

Monday, February 11, 2013

That "Free" Research You Get From Your Broker May Be Worth What You Paid for It


Conflicts of interest can be hard to spot from the inside, while they seem obvious to those on the outside. That's, of course, one of the things that makes such conflicts so complicated.

I've been thinking about conflicts of interest, and how to structure organizations to reduce their frequency, since reading Saturday's New York Times column by James B. Stewart on analysts' bullish recommendations on Apple stock, long after it started its current slide (it is now down by about one-third since its September 2012 peak). The entire column can be found here.

As Stewart noted, we have been aware of conflicts of interest in the banking and brokerage arenas for some time. A decade ago, "There were some notorious examples of analysts who curried favor with investment banking clients and potential clients by producing favorable research, and then were paid huge bonuses out of investment banking fees."

Those lapses seem outrageous to outsiders, but probably didn't to those on the inside at the time. It was just "how the business works". And we know that humans are stunningly bad at knowing how easily they are manipulated, how quickly they respond to even small rewards (hello, "gimme" caps!). So if you had asked an analyst at the time whether the fact that her bonus was paid by investment banking fees influenced her recommendations, she would have been insulted at the very thought.

Since then, thanks to Congressional and state investigations and the passage of several laws, including Sarbanes-Oxley, "investment banking and research operations were segregated. Conflicts had to be disclosed, and research and analyst pay was detached from investment banking revenues...."

So far, so good.

So how could analysts still be saying, "Buy, Buy," about Apple, when the stock is slipping? What else is going on?

A key problem, according to Prof. Stuart Gilson of Harvard Business School, is that "research is funded through the trading desks."

In other words,
If you're an analyst and one way your report brings in revenue is through increased trading, a buy recommendation will do this more than a sell. For a sell, you have to already own the stock to generate a trade. But anybody can potentially buy a stock. That's one hypothesis about why you still see a disproportionate number of buy recommendations.

But fixing all the conflicts -- even if that were truly possible -- might not solve all the problems. Analysts, it appears, fall into many of the same traps we ordinary investors do, such as extrapolating past performance into the future.

Moreover, like many of us, analysts "have a tendency to tell their audience what it wants to hear."

How can an organization fix that problem?

Carlo Besenius, "the only analyst who even came close to calling the peak in Apple's stock", isn't employed by an investment bank or a brokerage firm. Instead, he runs his own firm, founded a decade ago after many years in brokerage-house research.
I'm paid based on performance.... I have to go to my clients and explain why they should pay for my research when they can get it for nothing from the firms were they pay their trading commissions.

You know what they say about advice? It's worth what you pay for it....